<PAGE> 1
FORM 8-A
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
BARR LABORATORIES, INC.
(Exact name of Registrant as specified in its charter)
New York 22-1927534
(State of incorporation (I.R.S. Employer
or organization) Identification No.)
Two Quaker Road,
Pomona, New York 10970-0519
(Address and Zip Code of Registrant's principal executive officer)
Securities to be registered pursuant to Section 12(b) of the Act:
Title of each class Name of each exchange on which
to be so registered each class is to be registered
Common Stock ($.01 par value) New York Stock Exchange, Inc.
If this form relates to the registration of a class of securities
pursuant to Section 12(b) of the Exchange Act and is effective pursuant to
General Instruction A.(c), check the following box. |X|
If this form relates to the registration of a class of securities
pursuant to Section 12(g) of the Exchange Act and is effective pursuant to
General Instruction A.(d), check the following box. |_|
Securities Act registration statement file number to which this form relates:
Not applicable
Securities to be registered pursuant to Section 12(g) of the Act:
None
<PAGE> 2
INFORMATION REQUIRED IN REGISTRATION STATEMENT
Item 1. Description of Registrant's Securities to be Registered.
The title of the class being registered is Common Stock, par value $.01
per share.
Holders of the Common Stock are entitled to one vote for each share
held of record, in person or by proxy, at all meetings of the shareholders and
on all propositions before such meetings. The Common Stock does not have
cumulative voting rights in the election of directors. Holders of the Common
Stock have no preemptive, subscription, redemption or conversion rights. All
outstanding shares of Common Stock are fully paid and non-assessable. Holders of
Common Stock are entitled to such dividends as may be declared by the Board of
Directors out of funds legally available therefor. In the event of liquidation,
dissolution or winding up of the affairs of the Registrant, the assets remaining
after provision for payment of creditors and after distribution in full of the
preferred amount to be distributed to the holders of shares of any preferential
stock are distributable pro rata among holders of Common Stock.
Item 2. Exhibits
The following exhibits are filed with each copy of this Registration
Statement filed with the New York Stock Exchange, Inc. but not with the copies
of this Registration Statement filed with the Securities and Exchange
Commission:
1. Registrant's Annual Report on Form 10-K for the year ended
June 30, 1997.
2. Registrant's Quarterly Reports on Form 10-Q for the quarterly
periods ended September 30, 1997.
3. Registrant's Proxy Statement for Annual Meeting of
Shareholders held on December 3, 1997.
4.1 Registrant's Restated Certificate of Incorporation.
4.2 Registrant's Amended and Restated By-laws.
5. Specimen Common Stock Certificate.
6. Registrant's 1997 Annual Report to Shareholders.
<PAGE> 3
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange
Act of 1934, the Registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly authorized.
Barr Laboratories, Inc.
Date: January 30, 1998 By /s/PAUL M. BISARO
----------------------------
Paul M. Bisaro
Senior Vice President and
Secretary
